XML 23 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Director and Officer Trading Arrangements

The following table describes for the quarterly period ended December 31, 2024 each trading arrangement for the sale or purchase of Company securities adopted or terminated by our directors and officers that is either (1) a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), or a “Rule 10b5-1 trading arrangement,” or (2) a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K):

Name (Title)

Action Taken (Date of Action)

Type of Trading Arrangement

Nature of Trading Arrangement

Duration of Trading Arrangement

Aggregate Number of Securities

Amy Simon (Chief Medical Officer)

Adoption

(November 7, 2024)

Rule 10b5-1 trading arrangement

Sale

Until December 31, 2025, or such earlier date upon which all transactions are completed or expire without execution.

Up to 204,956 shares
Amy Simon  
Trading Arrangements, by Individual  
Name Amy Simon
Title Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date November 7, 2024
Expiration Date December 31, 2025
Arrangement Duration 419 days
Aggregate Available 204,956